[{"Assets_0_Q3_USD":2480994000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-74482000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":249815000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":768412000.0,"Ticker":"OPK","CIK":"944809","name":"OPKO HEALTH, INC.","OfficialName":"OPKO Health Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2187471532.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20181109"}]